Veon (VEON) EBITDA (2009 - 2026)

Veon's EBITDA history runs 18 years deep, the most recent figure standing at $517.0 million for Q1 2026.

• Quarterly EBITDA rose 17.77% year-over-year to $517.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 billion (up 87.15% YoY) and the FY2025 annual result came in at $1.4 billion, up 29.64% from the prior year.
• EBITDA was $517.0 million for Q1 2026 at Veon, down from $678.0 million in the prior quarter.
• Across five years, EBITDA topped out at $678.0 million in Q2 2025 and bottomed at $80.0 million in Q2 2022.
• A 5-year average of $281.2 million and a median of $200.5 million in 2023 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2022 — EBITDA soared 500.0% — and 2023, when it grew 10.06%.
• Veon's EBITDA stood at $169.0 million in 2022, then advanced by 10.06% to $186.0 million in 2023, then rose by 15.59% to $215.0 million in 2024, then surged by 215.35% to $678.0 million in 2025, then fell by 23.75% to $517.0 million in 2026.
• Business Quant data shows VEON's EBITDA at $517.0 million in Q1 2026, $678.0 million in Q2 2025, and $439.0 million in Q1 2025.